This report examines current barriers to access to psychotropic medicines and identifies key actions for overcoming those barriers. Further, it provides evidence-based guidance for appropriate use of medicines in people with mental disorders.
This report examines current barriers to access to psychotropic medicines and identifies key actions for overcoming those barriers. Further, it provides evidence-based guidance for appropriate use of medicines in people with mental disorders.